Overview
Eric Sigler is an Ophthalmologist in Riverhead, New York. Dr. Sigler is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Central Serous Chorioretinopathy, Punctate Inner Choroidopathy, Diabetic Retinopathy, and Late-Onset Retinal Degeneration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
54 Commerce Ave, Suite 6, Riverhead, NY 11901
585 Broadway, Massapequa, NY 11758
Howard Charles is an Ophthalmologist in Mount Kisco, New York. Dr. Charles is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Diabetic Retinopathy.
Yale University
Anthony Daniels is an Ophthalmologist in New Haven, Connecticut. Dr. Daniels is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, and Metastatic Uveal Melanoma. Dr. Daniels is currently accepting new patients.
Refocus Eye Health Of Central Connecticut PC
David Tom is an Ophthalmologist in Westport, Connecticut. Dr. Tom is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Retinal Vein Occlusion.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Sigler isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Central Serous ChorioretinopathyDr. Sigler isDistinguished. Learn about Central Serous Chorioretinopathy.
- Diabetic RetinopathyDr. Sigler isDistinguished. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationDr. Sigler isDistinguished. Learn about Late-Onset Retinal Degeneration.
- NeuroretinitisDr. Sigler isDistinguished. Learn about Neuroretinitis.
- Punctate Inner ChoroidopathyDr. Sigler isDistinguished. Learn about Punctate Inner Choroidopathy.
- Advanced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Choroid Plexus CarcinomaDr. Sigler isAdvanced. Learn about Choroid Plexus Carcinoma.
- Cone DystrophyDr. Sigler isAdvanced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Sigler isAdvanced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Sigler isAdvanced. Learn about Doyne Honeycomb Retinal Dystrophy.
- Experienced
- Bietti Crystalline Dystrophy (BCD)Dr. Sigler isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- CataractDr. Sigler isExperienced. Learn about Cataract.
- EndophthalmitisDr. Sigler isExperienced. Learn about Endophthalmitis.
- Geographic AtrophyDr. Sigler isExperienced. Learn about Geographic Atrophy.
- Gyrate Atrophy of the Choroid and Retina
- HyphemaDr. Sigler isExperienced. Learn about Hyphema.